LC-MS/MS-BASED SERUM PROTEOMICS REVEALS A DISTINCTIVE SIGNATURE IN A RHEUMATOID ARTHRITIS MOUSE MODEL AFTER TREATMENT WITH MESENCHYMAL STEM CELLS.

LC-MS/MS-based serum proteomics reveals a distinctive signature in a rheumatoid arthritis mouse model after treatment with mesenchymal stem cells.

Mesenchymal stem cells (MSCs) are known to be able to modulate immune responses, possess tissue-protective properties, and exhibit healing capacities with therapeutic potential for various diseases.The ability of MSCs to secrete various cytokines and growth factors provides new insights into autoimmune-diseases such as rheumatoid arthritis (RA).RA

read more